These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33122336)

  • 1. Validation of Lung EpiCheck, a novel methylation-based blood assay, for the detection of lung cancer in European and Chinese high-risk individuals.
    Gaga M; Chorostowska-Wynimko J; Horváth I; Tammemagi MC; Shitrit D; Eisenberg VH; Liang H; Stav D; Levy Faber D; Jansen M; Raviv Y; Panagoulias V; Rudzinski P; Izbicki G; Ronen O; Goldhaber A; Moalem R; Arber N; Haas I; Zhou Q
    Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 33122336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
    Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
    J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection and stratification of lung cancer aided by a cost-effective assay targeting circulating tumor DNA (ctDNA) methylation.
    Wang Z; Xie K; Zhu G; Ma C; Cheng C; Li Y; Xiao X; Li C; Tang J; Wang H; Su Z; Liu D; Zhang W; Huang Y; Tang H; Liu R; Li W
    Respir Res; 2023 Jun; 24(1):163. PubMed ID: 37330511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a serum miRNA panel for detection of early stage non-small cell lung cancer.
    Ying L; Du L; Zou R; Shi L; Zhang N; Jin J; Xu C; Zhang F; Zhu C; Wu J; Chen K; Huang M; Wu Y; Zhang Y; Zheng W; Pan X; Chen B; Lin A; Tam JKC; van Dam RM; Lai DTM; Chia KS; Zhou L; Too HP; Yu H; Mao W; Su D
    Proc Natl Acad Sci U S A; 2020 Oct; 117(40):25036-25042. PubMed ID: 32943537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood test shows high accuracy in detecting stage I non-small cell lung cancer.
    Goebel C; Louden CL; Mckenna R; Onugha O; Wachtel A; Long T
    BMC Cancer; 2020 Feb; 20(1):137. PubMed ID: 32085733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
    Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
    Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity.
    Zang R; Wang X; Jin R; Lei Y; Huang J; Liu C; Zheng S; Zhou F; Wu Q; Sun N; Gao S; He J
    J Transl Med; 2019 Dec; 17(1):430. PubMed ID: 31888670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
    Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
    Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC).
    Liao J; Shen J; Leng Q; Qin M; Zhan M; Jiang F
    Thorac Cancer; 2020 Mar; 11(3):762-768. PubMed ID: 31994346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of non-metastatic non-small-cell lung cancer in urine by methylation-specific PCR analysis: A feasibility study.
    Wever BMM; Bach S; Tibbesma M; Ter Braak TJ; Wajon D; Dickhoff C; Lissenberg-Witte BI; Hulbert A; Kazemier G; Bahce I; Steenbergen RDM
    Lung Cancer; 2022 Aug; 170():156-164. PubMed ID: 35793574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations.
    Dai J; Lv J; Zhu M; Wang Y; Qin N; Ma H; He YQ; Zhang R; Tan W; Fan J; Wang T; Zheng H; Sun Q; Wang L; Huang M; Ge Z; Yu C; Guo Y; Wang TM; Wang J; Xu L; Wu W; Chen L; Bian Z; Walters R; Millwood IY; Li XZ; Wang X; Hung RJ; Christiani DC; Chen H; Wang M; Wang C; Jiang Y; Chen K; Chen Z; Jin G; Wu T; Lin D; Hu Z; Amos CI; Wu C; Wei Q; Jia WH; Li L; Shen H
    Lancet Respir Med; 2019 Oct; 7(10):881-891. PubMed ID: 31326317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of lung cancer in silicosis patients using a tumor-marker panel.
    Schneider J
    Cancer Biomark; 2010; 6(3-4):137-48. PubMed ID: 20660960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accurate detection of early-stage lung cancer using a panel of circulating cell-free DNA methylation biomarkers.
    Hu S; Tao J; Peng M; Ye Z; Chen Z; Chen H; Yu H; Wang B; Fan JB; Ni B
    Biomark Res; 2023 Apr; 11(1):45. PubMed ID: 37101220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).
    Liang W; Zhao Y; Huang W; Gao Y; Xu W; Tao J; Yang M; Li L; Ping W; Shen H; Fu X; Chen Z; Laird PW; Cai X; Fan JB; He J
    Theranostics; 2019; 9(7):2056-2070. PubMed ID: 31037156
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of a multiplex methylation specific PCR suitable for (early) detection of non-small cell lung cancer.
    Nawaz I; Qiu X; Wu H; Li Y; Fan Y; Hu LF; Zhou Q; Ernberg I
    Epigenetics; 2014 Aug; 9(8):1138-48. PubMed ID: 24937636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood FOLR3 methylation dysregulations and heterogeneity in non-small lung cancer highlight its strong associations with lung squamous carcinoma.
    Qu Y; Zhang X; Qiao R; Di F; Song Y; Wang J; Ji L; Zhang J; Gu W; Fang Y; Han B; Yang R; Dai L; Ouyang S
    Respir Res; 2024 Jan; 25(1):59. PubMed ID: 38273401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA.
    Ooki A; Maleki Z; Tsay JJ; Goparaju C; Brait M; Turaga N; Nam HS; Rom WN; Pass HI; Sidransky D; Guerrero-Preston R; Hoque MO
    Clin Cancer Res; 2017 Nov; 23(22):7141-7152. PubMed ID: 28855354
    [No Abstract]   [Full Text] [Related]  

  • 18. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer.
    Lam S; Boyle P; Healey GF; Maddison P; Peek L; Murray A; Chapman CJ; Allen J; Wood WC; Sewell HF; Robertson JF
    Cancer Prev Res (Phila); 2011 Jul; 4(7):1126-34. PubMed ID: 21733826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A panel of DNA methylation biomarkers for detection and improving diagnostic efficiency of lung cancer.
    Wei B; Wu F; Xing W; Sun H; Yan C; Zhao C; Wang D; Chen X; Chen Y; Li M; Ma J
    Sci Rep; 2021 Aug; 11(1):16782. PubMed ID: 34408226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.